KRAS and lung carcinoma: KRAS is the principal isoform of RAS, and somatic mutations in KRAS are associated with over 21% of all cancers; a particularly high frequency of KRAS mutations is observed in pancreatic, colorectal and lung cancers, three of the top four leading causes of new cancer deaths4.